ENGAGEMENT WITH REGULATORY AGENCIES
Letters to Federal Agencies
July 20, 2020 -
MHPA Sends Comments to CMS-2482-P- Proposed Rule: Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements
MHPA sent comments to CMS Administrator Seema Verma for the proposed rule, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements.
READ LETTER
July 20, 2020 -
MHPA Sends Medicaid Provider and Plan Letter on MFAR's Impact to HHS/CMS
MHPA joined with six other national organizations sending a letter requesting that the Department of Health and Human Services and the Centers for Medicare and Medicaid Services (CMS) pause work on the Medicaid Fiscal Accountability Rule (MFAR) during this time of COVID-19 and urge thoughtful consideration of the long-term impact of the policy.
READ LETTER
July 9, 2020 -
Letter to CMCS regarding Safeguarding Medicaid Program Sustainability through State-Medicaid Managed Care Partnerships
MHPA sent a letter to CMCS Director Calder Lynch requesting that CMS issue guidance to help protect the continued viability of state-Medicaid managed care partnerships and the long-term sustainability of the Medicaid program. - READ LETTER
May 29, 2020 -
RFI Response regarding Maternal and Infant Health Care in Rural Communities
MHPA responded to the Office of Minority Health’s (OMH) request for information (RFI) regarding maternal and infant care in rural communities. The letter commended the Committee's continued leadership and commitment to improving health care access, quality, and outcomes for women and infants in our nation’s rural communities. - READ LETTER
May 8, 2020 -
Letter to HHS Secretary, Medicaid Directors on Supporting Critical Medicaid Providers
MHPA joins with seven other organizations in writing HSS Secretary Azar to urge for the urgency of expeditiously delivery federal financial relief to Medicaid providers and to offer ongoing assistance for future action. - READ LETTER
May 8, 2020 -
Letter on CARES Act Funding and Medicaid Providers Sent to HHS Secretary
MHPA sent a letter to Secretary Azar offering recommendations and to encourage taking action to ensure access to care today and in the future for the vulnerable Medicaid and Dually Eligible populations who access care and services through the Medicaid health care delivery system. - READ LETTER
May 4, 2020 -
Letter to FCC Regarding Lifeline Program and Responses to the COVID-19 Pandemic
MHPA joined with other organizations in requesting that the Federal Communications Commission (FCC) consider certain actions to expand the availability of the Lifeline program during the current COVID-19 public health emergency. - READ LETTER
April 17, 2020 -
LTSS Workforce Sign-on Letter to White House
March 23, 2020 -
Response Letter to to the HHS Secretary and CMS Administrator on Coordinating Care from Out-of-State Providers for Medicaid-Eligible Children with Medically Complex
RIN 0938-ZB57 - Request for Information - CMS-2324-NC - READ LETTER
March 11, 2020 -
Letter to CMS on COVID-19
January 31, 2020 -
MHPA Comments on Medicaid Fiscal Accountability in Proposed Regulation
Federal Register, Vol. 84, No. 222, November 18, 2019 [CMS-2393-P] and Federal Register, Vol. 84, No. 249, December 30, 2019 [CMS-2393-N] - READ LETTER
January 13, 2020 -
Letter to Center for Medicaid and Chip Services (CMCS)
Use of Underwriting Gain Assumption Models & Suggested Additions to 2020-2021 Medicaid Managed Care Rate Setting Development Guide . - READ LETTER
December 19, 2019 -
MHPA Sends Letter to CMS Asking for Extension to Comment Period
Concerned over the limited timeframe available for stakeholders to offer meaningful comments before the mid-January deadline, MHPA sent its own letter to CMS asking for an extension to the comment period given the complexity of the Medicaid regulation proposals can have on beneficiaries and the current health care delivery system. - READ LETTER
December 18, 2019 -
MHPA Joins with Partnership for Medicaid to Request CMS Extend Rulemaking Comment Period for 60 Days
MHPA joined with the Partnership for Medicaid to request CMS extend the Medicaid fiscal accountability NPRM comment period for 60 days, time necessary to offer more meaningful comments and to fully assess the impact that these changes will have on the Medicaid Program and state budgets. - READ LETTER
November 7, 2019 -
MHPA Letter on CMCS Informational Bulletin
Medical Loss Ratio (MLR) Requirements Related to Third-Party Vendors - READ LETTER
June 3, 2019 -
MHPA Submit Comments to CMS on Two Comprehensive Regulations
MHPA Comments to CMS–9115–P; Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability and Patient Access for Medicare Advantage Organization and Medicaid Managed Care Plans, State Medicaid Agencies, CHIP Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans in the Federally-Facilitated Exchanges and Health Care Providers. As well as Comments to RIN 0955–AA01; 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program - READ LETTER
April 8, 2019 -
MHPA Comments on Fraud & Abuse, Safe Harbor Proposed Rules
MHPA Comments to OIG-0936-P; Proposed Rule: Fraud & Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. - READ LETTER
January 14, 2019 -
MHPA Comments to CMS on Proposed Rule for the Medicaid and CHIP
Medicaid Program; Medicaid and Children’s Health Insurance Plan (CHIP) Managed Care - READ LETTER
December 31, 2018 -
MHPA Response to Policy and Technical Changes to the Medicare Advantage, Prescription Drugs
Medicare and Medicaid Programs; Policy and Technical Changes to the Medicare Advantage,
Medicare Prescription Drug Benefit, Program of All-Inclusive Care for the Elderly (PACE),
Medicaid Fee-for-Service, and Medicaid Managed Care Programs for Years 2020 and 2021 - READ LETTER
July 31, 2018 -
MHPA Comments on Title X
Family Planning Program - Title X Notice of Rulemaking - READ LETTER
July 18, 2018 -
MHPA Comments on Drug Pricing
HHS Blueprint to Lower Drug Price and Reduce Out-of-Pocket Costs - READ LETTER
May 24, 2018 -
CMMI RFI on Directed Provider Contracting Models
May 14, 2018 -
MHPA Response to RFI on Inappropriate Steering
April 12, 2018 -
MHPA's Comments on Implementing the Dual Eligible Special Needs Plans (D-SNPs)
Comments on Section 50311. Request for Stakeholder Input(RFI) entitled “Implementing the Dual Eligible Special Needs Plans (D-SNPs) Provisions of the Bipartisan Budget Act of 2018 (Public Law No. 115-123)” issued on March 13, 2018. MHPA applauds CMS’ efforts to strengthen integration of care for dual eligible beneficiaries and to develop unified processes across programs to ensure access to seamless, coordinated care for vulnerable beneficiaries. - READ LETTER
January 16, 2018 -
MHPA Comments on Medicare Program
CMS-4182-P: Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program Proposed Rule - READ LETTER
October 17, 2016 -
MHPA Comments on the Proposed PACE Rule
MHPA believes that PACE Organizations (POs) and Medicaid MCOs play a key role in providing integrated acute and long-term services and supports (LTSS) to complex, vulnerable populations. - READ LETTER
State Waivers
June 27, 2018 -
MA 115 MHPA Wavier Comments
August 17, 2018 -
KY 115 MHPA Wavier Comments
January 5, 2018 -
NC 115 MHPA Wavier Comments
Resources
April 2, 2020 -
Final Interoperability Rules - Major Provisions & Comment Responses
Side-by-side comparison